sidebar, Insiders listed on SEDI include:

Eastern Capital Limited 27,712,879 shares (~11.4%)

NGN BioMed Opportunity II LP,  8,000,108 shares ( Director Peter Johann) (~3.2%)

Shenzhen Hepalink Pharmaceutical Ltd.,  85,286,524 (board seat held by Lu Shawn Shuguang) (~35.15%)

Non-Insider:

Vision Leader Limited subsidiary of ORI Star Fund LP, 16,100,000 ( board seat held by Dicky To, Partner of ORI Capital) (~6.64%)

Don't know of any others.

Koo